Those at the Endocrine Society believe “large scale, prospective, randomized controlled trials” are needed to decide what the risks and benefits are associated with testosterone therapy treatment. Specifically, the Endocrine Society wants trials involving older men who are experiencing a natural de
Stephani Victor, spokesperson for the Chaffin Luhana Foundation and Paralympic downhill skier, is headed for the Sochi 2014 Paralympic Winter Games. This year, NBC will be offering an unprecedented 52 hours of coverage of the events, allowing viewers to follow these impressive athletes. A traumatic…
An antipsychotic drug, Risperdal, was first marketed and FDA-approved to treat schizophrenia in adults in 1993. In 2003, it was approved to treat bipolar disorder, autism in children and teens in 2006 and in 2007 for children with schizophrenia, followed by an approval of the…
It is one of the largest health care fraud settlements in United States history. Janssen Pharmaceuticals Inc., and Johnson & Johnson, the parent company of the antipsychotic drug, Risperdal, will pay more than $2.2 billion in criminal and civil investigations. It was alleged that from…
The FDA is investigating the risk of heart attack, stroke and death among men taking different forms of testosterone therapy. This announcement came after two recent studies, one published in PLOS One, and the other in the Journal of the American Medical Association (JAMA). History…
Risperdal (risperidone) was the first antipsychotic drug marketed in the U.S. after clozapine. It was approved to treat schizophrenia in adults in 1993. The drug has since been linked to an increased risk for diabetes. A 2003 study published in the National Center for Biotechnology…
Risperdal, manufactured by Johnson & Johnson and its Janssen Pharmaceuticals subsidiary was approved for use by the FDA in 1993 to treat schizophrenia. Since then it was approved for use in 2003 for bipolar disorder, in 2006 for irritability in children and teenagers with autism,…
News of the FDA investigating the risk of heart attack, stroke and death in men taking testosterone therapy treatments appears to already be having an impact on the sale of the company’s stock, and not just in the United States. In an article published in…
Some patients who received St. Jude Eon Mini implant surgery have complained about reduced pain relief, a return of symptoms, suffered from burns, or needed the device removed after surgery. The FDA issued recalls after learning of potential issues with the Eon Mini battery and…
On February 4, 2014, Johnson & Johnson and Ethicon were ordered by a judge to pay for not preserving evidence in In re Ethicon, Inc. Pelvic Repair Systems Product Liability Litigation. This litigation comes after the U.S. Food and Drug Administration received reports from hundreds…
On February 4, 2014, five lawsuits were filed in Illinois federal court against AbbVie Inc., and Abbott Laboratories, Inc., the manufacturers of Androgel, a testosterone therapy treatment. This Androgel lawsuit comes just days after the U.S. Food and Drug Administration (FDA) announced that it is…
In April 2013, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Mirena lawsuits into one court in the Southern District of New York. About a month later, the Supreme Court of New Jersey also centralized state Mirena lawsuits into one court in…